Baker Bros. Advisors LP Acadia Pharmaceuticals Inc Put Options Transaction History
Baker Bros. Advisors LP
- $8.39 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|---|---|---|---|---|
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
Others Institutions Holding ACAD
# of Institutions
351Shares Held
165MCall Options Held
1.77MPut Options Held
307K-
Vanguard Group Inc Valley Forge, PA15.2MShares$332 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$264 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.54MShares$187 Million2.32% of portfolio
-
State Street Corp Boston, MA6.99MShares$153 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.68MShares$102 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.54B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...